Molecular pathogenesis of Chlamydia trachomatis

Abstract

Chlamydia trachomatis is a strict intracellular human pathogen. It is the main bacterial cause of sexually transmitted infections and the etiologic agent of trachoma, which is the leading cause of preventable blindness. Despite over 100 years since C. trachomatis was first identified, there is still no vaccine. However in recent years, the advancement of genetic manipulation approaches for C. trachomatis has increased our understanding of the molecular pathogenesis of C. trachomatis and progress towards a vaccine. In this mini-review, we aimed to outline the factors related to the developmental cycle phase and specific pathogenesis activity of C. trachomatis in order to focus priorities for future genetic approaches. We highlight the factors known to be critical for developmental cycle stages, gene expression regulatory factors, type III secretion system and their effectors, and individual virulence factors with known impacts.

1 Introduction

The sexually transmitted pathogen Chlamydia trachomatis (CT) is the leading cause of preventable blindness worldwide (Taylor et al., 2014) and the most common bacterial sexually transmitted infection (STIs) in humans, with approximately 131 million cases each year and rising (Newman et al., 2015). The majority of chlamydial infections are asymptomatic. The infection when diagnosed can be treated with antibiotics (Scidmore, 2009). Complications of CT infections are known to include reproductive tract impacts which can cause considerable morbidity and cost (Davies et al., 2016).

The Chlamydiae are a ubiquitous family of Gram-negative pathogens, with a unique lifecycle. Chlamydiae species causes infection in specific animals, such as Chlamydia muridarum in mice and hamsters (Mishkin et al., 2022), while Chlamydia psittaci commonly infects birds and rarely humans (Hogerwerf et al., 2020). Chlamydia pneumoniae and CT are endemic to humans, they infect different anatomical sites, respiratory and oculogenital, respectively (Whittum-Hudson and Hudson, 2005). CT is further divided into serovars based on the hypervariable region of the major outer membrane protein (MOMP) (Hepler et al., 2018). CT serovars exhibit different tissue tropisms. A-C infects ocular tissue and causes trachoma. D-K primarily infects the genital tract resulting in the STI ‘chlamydia’ but in newborns can also infect respiratory and ocular conjunctiva tissues causing pneumonia and conjunctivitis. L1-L3 infects genital tissues and macrophages resulting in the invasive STI ‘lymphogranuloma venereum (LGV)’ (Abdelsamed et al., 2013).

The Chlamydia developmental cycle is characterised as biphasic, relying on specific interactions with the host cell for nutrients in order to survive and replicate due to the reduced chlamydial genome (Gitsels et al., 2019). There are two main morphological bacterial phases; the extracellular infectious elementary body (EB) and the intracellular, non-infectious, replicative reticulate body (RB) [reviewed in (Hafner et al., 2008; Elwell et al., 2016; Witkin et al., 2017)] (Figure 1). The infectious EBs are robust formations with spore-like structures that consist of disulphide cross-linked outer membrane protein complex on the surface. The development cycle of CT can be impacted by environmental factors and stresses. Known stressors include nutrient deprivation, exposure to host cytokines, and cell wall synthesis-targeting antibiotics (Gitsels et al., 2019). Under these conditions, RBs transition to altered morphological forms of non-culturable, non-dividing, aberrantly enlarged “persistent” forms, called aberrant bodies (ABs) (Panzetta et al., 2018). These forms remain viable and can revert into an active infection once conditions are favourable (Schoborg, 2011).

Figure 1

As an obligate intracellular organism, virulence and pathogenic features interplay critically with host cellular factors and the host immune system which can also contribute to disease pathology [reviewed in (Geisler, 2010; Menon et al., 2015; Murthy et al., 2018; Chen et al., 2019)]. The intracellular nature and unusual bi-phasic developmental cycle has, until recently, hampered progress on biological investigations and genetic manipulation of Chlamydia. Recently, genetic methods have rapidly progressed and accordingly our understanding of pathogenic mechanisms has increased (Fisher and Beare, 2023). However, each genetic approach has their advantages and limitations [reviewed in, (Banerjee and Nelson, 2021; Wan et al., 2023)]. Previously, Chlamydia was thought to be genetically intractable due to its intracellular development, vacuole niche, evasive persistence mechanism, serovar genetic variability, and the thick wall of EB absorbing external DNA (Andersen et al., 2021). As such, specialised techniques were developed to better understand this clinically significant pathogen. Whole genome sequencing (Stephens et al., 1998), allelic exchange mutagenesis (Mueller et al., 2016), CRISPRi knockdown (Ouellette, 2018; Ouellette et al., 2021) and intron insertion gene inactivation (O'Neill et al., 2021) assist in associating genes with chlamydial phenotypic traits, bypassing impractical traditional approaches in genome studies [reviewed in (Read and Massey, 2014; Fisher and Beare, 2023; Luu et al., 2023)]. Nonetheless, many of these genetic manipulation approaches for Chlamydia are still relatively time consuming and requires expert culture skills, hence we set out to review what is known about potential virulence factors to guide priorities for future genetic experiments. We do not cover metabolic factors, although it is arguable that these are related to pathogenesis for an obligate intracellular pathogen. We also do not cover unknown hypothetical proteins.

2 Transcription and regulatory factors as a target to understand pathogenesis

The bi-phasic development is regulated by transcription factors resulting in distinct gene expression profiles characterised as early, mid-, or late response. Chlamydia’s genome encodes a small number of known transcription factors (outlined in Table 1A) and sigma factors (σ) (Akers et al., 2011). The trio of chlamydial sigma factors (σ⁶⁶, σ²⁸, and σ⁵⁴) serve as RNA polymerases to various promotor genes (Nicholson et al., 2003; Wurihan et al., 2021). Belland et al. (2003) detected σ²⁸ and σ⁵⁴ mRNA mid-development at 8 h PI (hours post infection), whilst σ⁶⁶ was detected earliest at 3 h PI. σ⁶⁶ is responsible for activating the majority of CT promoters, whilst select late genes rely on σ²⁸- or σ⁵⁴-dependent promoters (Mathews et al., 1999). These sigma factors are regulated by specific transcription factors (Table 1A) and anti-sigma factors. A comprehensive review of transcriptional regulation is available from Nicholson et al. (2003) and Belland et al. (2003).

To date, only two anti-sigma factors which inhibit σ⁶⁶ activity have been characterised: CT663, a T3SS Scc4 chaperone, and the switch-protein Regulator of Sigma B W (RsbW) kinase (Rao et al., 2009) (Thompson et al., 2015). RsbW forms a regulatory network with its own anti-anti-sigma factor RsbV1 and the phosphatase RsbU. The activity of RsbW is driven by the levels unphosphorylated RsbV1, where a deficit of RsbV1 drives the switch-kinase towards antagonizing σ⁶⁶, altering transcription of σ⁶⁶ development-related genes involved in metabolism and growth (Hanson et al., 2015; Thompson et al., 2015).

Recently, transcriptional profiles for the σ⁵⁴ regulon was generated using CtcC (an ATP-hydrolyzing response regulator for σ⁵⁴) mutants which further revealed the role of this sigma factor in membrane remodelling and incorporating T3SS effectors into EBs during RB differentiation into infectious EB progeny (Soules et al., 2020). These observations were supported by recent findings from Hatch and Ouellette (2023) which employed CRISPR interference (CRISPRi) gene knockdown of σ⁵⁴. Hatch and Ouellette (2023) also used CRISPRi to knockdown σ²⁸ and identified this sigma-factor to be epistatic of σ⁵⁴ and also involved in secondary RB differentiation.

The use of CRISPRi to knockdown and investigate sigma factors has provided new insights into how RB to EB differentiation is regulated (Swoboda et al., 2023). This approach should be adopted to investigate other transcriptional factors in CT (listed in Table 1A). It is likely that many regulators will be essential and cannot be inactivated, thus utilising CRISPRi to knockdown will clarify how critical their role is in the CT development cycle as well as determine their regulon.

3 Type III secretion system and effector proteins

A well-known pathogenic feature of C. trachomatis is the T3SS and their associated effector proteins (Bugalhão and Mota, 2019). The T3SS is composed of a needle-like injectosome apparatus, which secretes effector proteins directly from the chlamydial cytoplasm into the host cell. Specific chlamydial chaperone 4 (Scc4; formerly CT663) precisely regulates T3SS function through gene expression and effector networks (Gao et al., 2020). There are 80 speculated anti-host T3SS-secreted effectors (Betts-Hampikian and Fields, 2010).

The secreted effectors have a variety of functions, including; disrupting the cytoskeletal structure, evasion of host defences, and prevention of host cell apoptosis, described in Table 1B (Coburn et al., 2007). Evidence shows the T3SS not only translocates bacterial-encoded proteins into the eukaryotic host cell’s cytoplasm, but also into the inclusion’s lumen (da Cunha et al., 2017). Some effectors (e.g. TarP and TepP) confer protection against cellular immune response triggers, TLR2, NOD1, and STING (stimulator of interferon genes) (Murray and McKay, 2021). The stimulation of IFN-γ from STING results in activation of indoleamine 2,3-dioxygenase (IDO), an integral element of host defence by reducing tryptophan available for the organism. Tryptophan is crucial to CT pathogenesis and genital CT serovars are able to synthesise tryptophan if indole is present through a functional tryptophan synthase (trypA) gene while ocular strains cannot as trpA is inactivated (McClarty et al., 2006).

Currently, many proposed effectors remain unconfirmed and even more remain uncharacterised, with the only secretion evidence provided using heterologous T3SS expression systems. By utilising knockout genetics to disable the T3SS, followed by phenotypic and proteomic comparison of wildtype and T3SS-null strains will be important in confirming established and discovering new effectors as well as unravelling their functions.

3.1 Tarp

The extracellular translocated actin-recruiting phosphoprotein (TarP, CT456) is required in the early developmental stages (Table 1B) (Clifton et al., 2004). TarP is Slc-1-dependent and involved in chlamydial internalisation, and invasion of host cell (Mueller et al., 2014; Faris et al., 2020). TarP binds to the host cell’s major cytoskeletal component, actin. Phosphorylated TarP interacts with a multitude of host cell signalling molecules, as well as phosphatidylinositol 3-kinase (PI3K) and SHC-transforming protein 1 (SHC1), involved in diverse cell functions (e.g. growth, differentiation, motility, survival) (Shehat et al., 2021). TarP was also discovered to impair the highly conserved Hippo signalling pathway in infected epithelial cells, a previously unknown chlamydia-affected pathway involved in cell proliferation and death (Shehat et al., 2021).

3.2 TepP

The early translocator phosphoprotein, TepP, is the second Slc-1-dependent effector and one of the few T3SS effectors where null mutants have been characterised (Chen et al., 2014). TepP is secreted by the T3SS to enhance CT infectivity and dampen host immune activation. TepP is localised near the inclusion in the eukaryotic cell’s cytosol, where it is phosphorylated by the host kinases (Carpenter et al., 2017). It then targets host factors CRK, PI3K and GSK3B to locally synthesise phosphoinositide-(3,4,5)-triphosphate (PIP3) and modulate host cell signalling in nascent infections. Specifically, PI3K is linked to inhibiting IFN-induced gene transcription within early inclusions. A TepP null-mutant displayed defected growth and altered host IFN-associated gene expression required to activate early immune responses (Chen et al., 2014). Recruitment of PI3K also suggests a role for TepP in modulating membrane vesicle trafficking events (Carpenter et al., 2017).

3.3 Inc proteins

Inc proteins or inclusion membrane proteins, share bilobed hydrophobic domains enabling anchoring to the inclusion membrane. Some Incs contain the presence of vesicle-targeting SNARE-like motifs in their coding sequence (e.g. IncA), which may facilitate host-pathogen interactions (Cingolani et al., 2019; Paumet et al., 2009).CT genome is predicted to encode 55 putative Inc proteins, with 37 confirmed (Weber et al., 2016). There is divergent Inc content across the Chlamydiaceae family, each possessing a distinct distribution pattern along the chlamydial inclusion membrane (Mital et al., 2013). IncA is required for inclusion vacuole fusion (Table 1B), other functions of Inc proteins include; a possible role in maintaining host cell viability (IncG) (Scidmore and Hackstadt, 2001; Verbeke et al., 2006) and as an early Inc, IncD may be important for establishing the inclusion as a replicative niche (Shaw et al., 2000), although further studies are required to confirm this. Chlamydial T3SS-secreted inclusion factors have been studied in greater detail by da Cunha et al. (2017), and Dehoux et al. (2011). Here, we focus on IncM, CTL0390 and CpoS which have been recently characterised.

The IncM effector targets host cell microtubules, as exhibited by its action in host cell multinucleation, centrosome positioning and Golgi distribution. This was found to impact inclusion morphology stabilisation, as IncM-null mutants exhibited defects in these areas, compared to wildtype strains (Luís et al., 2023).

The CTL0390 Inc effector is thought to play a role in mediating EB exit via host-cell lysis during the late stages. A CTL0390 mutant was observed to have reduced Golgi translocation of STING, which is likely required to regulate host-cell lysis for bacterial exit (Bishop and Derré, 2022).

Lastly, CpoS (chlamydial promoter of survival) suppresses apoptosis and necrosis of host cells to prolong chlamydial infection and increase infectivity (Sixt et al., 2017). CpoS affords protection from within the inclusion, thus can only counteract nearby pro-death host signalling (e.g. STING). CpoS-null mutants exhibited attenuated infections, with expedited clearance from murine genital tract models and reduce propagation in cell cultures. Recently, CpoS was found to block Rab GTPases required for lipid transport regulation, as well as the formation of inclusion microdomains of many Incs needed for pathogen-host cell interactions (i.e. IPAM, IncD and CT222) (Meier et al., 2023).

3.4 ChlaDUB

CT868 (ChlaDUB1/Cdu1) and CT867 (ChlaDUB2/Cdu2) are both deubiquitinases which are delivered to the host cytosol, but have differing impacts on CT infectivity. ChlaDUB1 is solely localised to the inclusion membrane where it deubiquinates the anti-apoptosis protein MCL-1. This prevents MCL-1 depletion and apoptosis, thus inhibiting premature host-cell death to allow EB progeny release and increasing infectivity (Fischer et al., 2017). ChlaDUB1 also prevents degradation of host glucose-transporter-1 (GLUT-1) proteins (Wang et al., 2017). This likely supports growth as knockdown of host GLUT-1 impairs C. trachomatis infection (Wang et al., 2017). Inactivation of ChlaDUB1 in CT also enhanced sensitivity to IFN-γ and reduced infectivity in murine infections (Fischer et al., 2017). Alternatively, inactivation of ChlaDUB2, which localises at the inclusion membrane and host cytosol, did not impair infection (Pruneda et al., 2018). However, both ChlaDUBs were found to be involved in Golgi fragmentation (Pruneda et al., 2018).

4 Adhesins

4.1 Ctad1

C. trachomatis adhesin 1 (Ctad1) is a highly conserved 47 kDa invasin encoded by CT017. It contains two SH3 (src Homology-3) domains located near the N-terminus. These domains are responsible for Ctad1 binding to integrin β1 subunits on human epithelial cells (Stallmann and Hegemann, 2016). Ctad1 is expressed on the surface of EBs and mediates C. trachomatis invasion. Upon binding to integrin β1, Ctad1 triggers activation of the host mitogen-activated protein kinase (MAPK) pathway leading to extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation and internalisation of EBs (Stallmann and Hegemann, 2016). Blocking of Ctad1 receptors with recombinant Ctad1 was shown to significantly reduce EB adhesion and internalisation, illustrating its role in virulence (Stallmann and Hegemann, 2016).

4.2 PMPs

Polymorphic membrane proteins (Pmps) are a group of type V autotransporter proteins unique to Chlamydiaceae, with variable numbers of Pmps encoded on the genomes. In CT, there are 9 Pmps and all nine are involved in adhesion (Becker and Hegemann, 2014).

Pmps consist of a signal peptide, an N-terminus passenger domain and a C-terminus β channel domain. The C-terminus domain allows translocation of the passenger domain through the outer membrane. After translocation through the outer membrane, Pmps can remain surface bound or be further cleaved and secreted into the inclusion. It has been suggested that the different cleavage of PmpD may lead to fragments with different functions (Swanson et al., 2009).

The expression of Pmps are temporally and developmentally driven. For instance, pmpA and pmpI expression peaked earliest at 12–18 hours post infection and were only detected in RBs (Nunes et al., 2007; Carrasco et al., 2011; Saka et al., 2011). This suggests that both proteins play an important role in RB development. In contrast, pmpD peaks mid-cycle at 12-24 hours post infection, whereas expression of other pmps (pmpB-H) occurred later (Kiselev et al., 2009). This indicates the latter’s involvement in the late stages (such as RB to EB transition) or early stages of infection (EB attachment) (Kiselev et al., 2009; Carrasco et al., 2011; Saka et al., 2011). Remarkably, the expression of the same pmp can vary drastically between different strains (Tan et al., 2009) and even in different inclusions for the same culture (Tan et al., 2010). Besides pmpG, the regulatory mechanism behind Pmp variation is unknown. The flexibility to alter Pmps expression may allow CT to evade antibody recognition targeted against a specific Pmp.

The importance of Pmps as adhesins in CT pathogenesis is best characterised in PmpD. Pre-incubation with recombinant PmpD was found to inhibit CT attachment (Becker and Hegemann, 2014). CT PmpD null mutants also had a 70% reduced host cell attachment and decreased RBs attached to the inclusion membrane, suggesting an additional role for PmpD in maintaining RB-inclusion interactions (Kari et al., 2014). Infection in non-human primates with these PmpD null mutants showed decreased chlamydial burden illustrating its role in pathogenesis (Kari et al., 2014). Although all Pmps are involved in adhesion, it remains unclear what the relative importance of each Pmp to CT is. pmpA, pmpD and pmpI are the most conserved CT Pmp genes and their expression are also unaffected by penicillin-induced stress, suggesting a greater selection pressure to maintain those genes relative to other Pmps (Carrasco et al., 2011).

Pmps may also play an important role in modulating the immune response. In C. pneumoniae and C. psittaci, the N-terminal Pmp21/PmpD activates Toll-like receptor 2 (TLR2), myeloid differentiation factor 88 (MYD88) and nuclear factor κB (NF-κB) signalling leading to Th2 polarised macrophages and upregulation of various cytokines/chemokines including IL-8, IL-6, IL-10 and monocyte chemoattractant protein-1 (MCP-1) (Wehrl et al., 2004). Importantly, Th2 polarised macrophages were associated with reduced nitric oxide (NO) production and Chlamydia killing (Chu et al., 2020). Whether CT Pmps also can modulate the host immune response remains to be seen.

Finally, genomic evidence has suggested that Pmps may be associated with tissue tropism and adaptation. Phylogenetic typing using 6 pmp genes (pmpB, pmpC, pmpF, pmpG, pmpH and pmpI) were able to separate CT strains into their respective biovars and serotypes (Gomes et al., 2006) These genes were under positive selection in one or more niches (Borges et al., 2012), suggesting that Pmps are involved in driving specific host-cell interactions or disease outcomes. However, the mechanisms of how these unique Pmp mutations contribute to phenotypic or virulence differences in CT are yet to be elucidated and are likely to benefit from fluorescence-reported allelic exchange mutagenesis (FRAEM) approaches now available (Mueller et al., 2016).

5 Cytotoxin

The human CT urogenital serovars (D-K) encode a partial 73 kDa cytotoxin (CT166) (Carlson et al., 2004). This cytotoxin was found to contain a functional glycosyltransferase DXD domain and UDP-glucose binding domain with significant homology to the large cytotoxins (LCT) from Clostridioides difficile (Belland et al., 2001). The chlamydial cytotoxin is responsible for the cytopathic ballooning effects seen in infected host cells by glucosylating the Rho-GTPase protein, Rac1. This inactivates Rac1 leading to actin remodelling (Thalmann et al., 2010). In addition to Rac1, the cytotoxin also glucosylates other small GTPases including H-Ras, K-Ras and N-Ras. This was found to inhibit ERK1/2 and P13K/Akt signalling pathways leading to reduced cell cycle progression, division, and migration (Bothe et al., 2015). Crucial to Rac1 and Ras glucosylation is the DXD motif with mutations in this motif shown to abrogate glucosylation (Thalmann et al., 2010; Bothe et al., 2015). However, DXD mutated cytotoxin was still capable of reducing cellular migration suggesting that there may be other toxin effects independent to the DXD motif (Bothe et al., 2015).

Currently, the importance and role of the cytotoxin in CT pathogenesis is unclear. CT166 is present in EBs at the start of infection but is rapidly degraded after 2 hours post-infection (Belland et al., 2001). This suggests potential importance in the initial stages of infection. Ectopic overexpression of CT166 in HeLa cells reduced CT uptake. It was suggested that the chlamydial cytotoxin controls Chlamydia uptake and functions to limit excessive actin polymerisation from other virulence factors such as Tarp (Thalmann et al., 2010). The cytotoxin has also been hypothesised to preserve host energy and nutrients for Chlamydia by limiting energy intensive processes such as cell division and migration (Bothe et al., 2015).

Only urogenital serovars encode a functional cytotoxin. In ocular serovars, the glycosyltransferase domain is deleted while in LGV serovars, both domains are absent (Carlson et al., 2004). It has been argued that the progressive loss of the cytotoxin gene in CT compared to other Chlamydia species like C. muridarum, which encodes 3 paralogous copies, may reflect host adaptation and that the cytotoxin is redundant for human infection.

6 Plasmid

Chlamydia retains a highly conserved ~7.5 kb virulence plasmid that was found to be significant in vivo (Zhong, 2016). The plasmid encodes 8 glycoproteins (pGP1-8) that have a variety of functions including promoting infection ascension, inducing pro-inflammatory responses, and promoting extrusion processes. pGP4, is a putative transcriptional regulator of both plasmid and chromosomal genes (Turman et al., 2023). Virulence plasmid-deficient or pGP3-deficient strains resulted in attenuated infections (Carlson et al., 2008). Under stressful conditions, CT plasmid copy numbers increase, presumably to upregulate T3SS-secreted substrates and ensure in vivo survival (Dirks et al., 2021).

Expression of pGP3 is regulated by pGP4, which similarly is involved in regulating expression of chromosomal glycogen synthase (GlgA), and other proteins with currently unknown functions in pathogenesis, CT050, CT143, and CT144 (Lei et al., 2021). pGP4 was proposed to serve as a plasmid pGP4-dependent secretion system, imperative for delivering pGP3 and GlgA to the host cytosol to increase host glycogen stores (Lei et al., 2021). Contrary to previous results from (da Cunha et al., 2017) this secretion was independent of the T2SS and T3SS (Lei et al., 2021). pGP4-deficient CT strains demonstrate varied transcription of chromosomal and plasmid genes, responsible for various duties (e.g. glycogen synthesis and inclusion morphology) within the developmental cycle that impact virulence (Song et al., 2013). Additionally, pGP4 has been implicated in boosting Euo’s ability to bind and repress Euo-dependent transcription promoters (Table 1A), thus temporally altering late gene expression necessary for RB differentiation into infectious progeny (Zhang et al., 2020). However, plasmid-deficient CT is also capable of inducing sequelae as severe as wild-type strains containing the plasmid (Qu et al., 2015). Thus, the exact role of chlamydial plasmid’s function in pathogenesis remains unknown but can be investigated using new techniques such as FRAEM to create gene deletions (Mueller et al., 2016; Ghosh et al., 2020; Fields et al., 2022).

7 Other characterised chlamydial virulence factors

CT’s pathogenesis is additionally mediated by various proteases and membrane proteins. HtrA (DegP) is a periplasmic serine protease with chaperone functions, including proteolysis of abnormal or misfolded proteins, and serves as a stress response protein that is upregulated in some persistence and stress models (e.g. high temperatures, antibiotics) (Huston et al., 2007; Huston et al., 2008). Little was known about the exact role HtrA played in Chlamydia’s pathogenesis prior to inhibition studies with JO146 (Patel et al., 2014). This inhibitor was most effective in CT’s mid-replication cycle, where administration of the drug resulted in a significant loss in overall vacuole size and in viable infectious EB progeny (Gloeckl et al., 2013; Ong et al., 2013; Lawrence et al., 2016).

Chlamydia Protease-like Activity Factor (CPAF) is a secreted protease that was initially thought to degrade dozens of host proteins involved in Golgi reorganisation, apoptosis, cytoskeleton remodelling and immune regulation. However, these initial CPAF targets identified were disproven as artefacts from in vitro post-lysis degradation, as CPAF is not inhibited by standard protease inhibitors (Chen et al., 2012). To clarify the role of CPAF, a reverse genetics approach re-established CPAF’s likely functions in targeting specific host cell proteins (i.e. vimentin and lamin-associated protein 1) impacting on late stages of infection and development of infectious progeny, however CPAF is not essential for either process (Snavely et al., 2014). Additional experiments also revealed CPAF as a key factor for evading host immune response by paralysing early recruitment of polymorphonuclear cells. Secreted CPAF cleaves FPR2 on the surface of neutrophils, inhibiting their activation, oxidative bursts and production of neutrophil extracellular traps thus establishing longer infections (Rajeeve et al., 2018).

Other important CT proteases include Ptr which is localised to the inclusion lumen and is expressed throughout CT’s development. A CT LGV-L2 ptr-null mutant demonstrated impaired genome replication after IFN-γ removal, along with decreased progeny generation (Panzetta et al., 2019). This links Ptr’s role in recovering from IFN-γ-induced persistence. The periplasmic Tail-specific protease, Tsp, has also been identified as critical for the differentiation from RB to EB via genetic approaches which alter Tsp expression levels (Swoboda et al., 2023).

Lastly, the major outer membrane protein (MOMP) is an immunodominant antigen. It functions as a porin, a cytoadhesin, and is the dominant component of the outer membrane complex that maintains EB stability (Wang et al., 2006; Guifeng et al., 2007).

8 Discussion and conclusion

Genetic approaches to investigate CT are still time consuming and technically difficult. Genome wide genetic manipulation and screening approaches remain challenging. Therefore, selective approaches to genetic manipulation guided by current knowledge of virulence functions, homolog functions, etc. has been used to target loci for genetic manipulation. These genetic approaches in CT have already confirmed the role of several established virulence factors while also overturning or disputing other widely-held understandings in Chlamydia pathogenesis such as the role of the T3SS in secreting plasmid regulated chromosomally-encoded proteins and the role of CPAF (Snavely et al., 2014; Lei et al., 2021). While significant advances in genetic approaches have been made in CT, the progress in other Chlamydia species remains behind. Application or modification of genetic approaches in CT like CRISPRi to other species will allow comparative studies to reveal important determinants of host tropism. Moreover, the recent development of a multiplexed CRISPRi knockdown system in CT is an exciting advancement which will allow interactions between two or more genes to be investigated, providing a more wholistic systems understanding of chlamydia pathogenesis (Hatch and Ouellette, 2023). Ultimately, rapidly expanding the arsenal of genetically investigated virulence factors in CT could inform novel treatment approaches or future attempts to develop a live attenuated vaccine strain.

References

• 1

  AbdelsamedH.PetersJ.ByrneG. I. (2013). Genetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropism. Future Microbiol.8 (9), 1129–1146. doi: 10.2217/fmb.13.80

  • CrossRef
  • Google Scholar

• 2

  AkersJ. C.HoDacH.LathropR. H.TanM. (2011). Identification and functional analysis of CT069 as a novel transcriptional regulator in chlamydia. J. Bacteriol.193 (22), 6123–6131. doi: 10.1128/JB.05976-11

  • CrossRef
  • Google Scholar

• 3

  AkersJ. C.TanM. (2006). Molecular mechanism of tryptophan-dependent transcriptional regulation in Chlamydia trachomatis. J. Bacteriol.188 (12), 4236–4243. doi: 10.1128/JB.01660-05

  • CrossRef
  • Google Scholar

• 4

  AndersenS. E.BulmanL. M.SteiertB.FarisR.WeberM. M. (2021). Got mutants? How advances in chlamydial genetics have furthered the study of effector proteins. Pathog. Dis.79 (2), ftaa078. doi: 10.1093/femspd/ftaa078

  • CrossRef
  • Google Scholar

• 5

  ArchuletaT. L.DuY.EnglishC. A.LoryS.LesserC.OhiM. D.et al. (2011). The chlamydia effector chlamydial outer protein N (CopN) sequesters tubulin and prevents microtubule assembly. J. Biol. Chem.286 (39), 33992–33998. doi: 10.1074/jbc.M111.258426

  • CrossRef
  • Google Scholar

• 6

  BanerjeeA.NelsonD. E. (2021). The growing repertoire of genetic tools for dissecting chlamydial pathogenesis. Pathog. Dis.79 (5), ftab025. doi: 10.1093/femspd/ftab025

  • CrossRef
  • Google Scholar

• 7

  BaoX.NickelsB. E.FanH. (2012). Chlamydia trachomatis protein GrgA activates transcription by contacting the nonconserved region of σ66. Proc. Natl. Acad. Sci.109 (42), 16870–16875. doi: 10.1073/pnas.1207300109

  • CrossRef
  • Google Scholar

• 8

  BartaM. L.HickeyJ. M.AnbanandamA.DyerK.HammelM.HeftyP. S. (2014). Atypical response regulator ChxR from Chlamydia trachomatis is structurally poised for DNA binding. PloS One9 (3), e91760–e91760. doi: 10.1371/journal.pone.0091760

  • CrossRef
  • Google Scholar

• 9

  BeckerE.HegemannJ. H. (2014). All subtypes of the Pmp adhesin family are implicated in chlamydial virulence and show species-specific function. MicrobiologyOpen3 (4), 544–556. doi: 10.1002/mbo3.186

  • CrossRef
  • Google Scholar

• 10

  BellandR. J.ScidmoreM. A.CraneD. D.HoganD. M.WhitmireW.McClartyG.et al. (2001). Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc. Natl. Acad. Sci.98 (24), 13984–13989. doi: 10.1073/pnas.241377698

  • CrossRef
  • Google Scholar

• 11

  BellandR. J.ZhongG.CraneD. D.HoganD.SturdevantD.SharmaJ.et al. (2003). Genomic transcriptional profiling of the developmental cycle of chlamydia trachomatis. Proc. Natl. Acad. Sci.100 (14), 8478–8483. doi: 10.1073/pnas.1331135100

  • CrossRef
  • Google Scholar

• 12

  Betts-HampikianH. J.FieldsK. A. (2010). The chlamydial type III secretion mechanism: revealing cracks in a tough nut. Front. Microbiol.1. doi: 10.3389/fmicb.2010.00114

  • CrossRef
  • Google Scholar

• 13

  BishopR. C.DerréI. (2022). The Chlamydia trachomatis Inclusion Membrane Protein CTL0390 Mediates Host Cell Exit via Lysis through STING Activation. Infect. Immun.90 (6), e0019022–e0019022. doi: 10.1128/iai.00190-22

  • CrossRef
  • Google Scholar

• 14

  BorgesV.NunesA.FerreiraR.BorregoM. J.GomesJ. P. (2012). Directional Evolution of Chlamydia trachomatis towards Niche-Specific Adaptation. J. Bacteriol.194 (22), 6143–6153. doi: 10.1128/JB.01291-12

  • CrossRef
  • Google Scholar

• 15

  BotheM.DutowP.PichA.GenthH.KlosA. (2015). DXD motif-dependent and -independent effects of the chlamydia trachomatis cytotoxin CT166. Toxins7 (2), 621–637. doi: 10.3390/toxins7020621

  • CrossRef
  • Google Scholar

• 16

  BugalhãoJ. N.MotaL. J. (2019). The multiple functions of the numerous Chlamydia trachomatis secreted proteins: the tip of the iceberg. Microbial Cell6 (9), 414–449. doi: 10.15698/mic2019.09.691

  • CrossRef
  • Google Scholar

• 17

  BullockH. D.HowerS.FieldsK. A. (2012). Domain analyses reveal that chlamydia trachomatis CT694 protein belongs to the membrane-localized family of type III effector proteins. J. Biol. Chem.287 (33), 28078–28086. doi: 10.1074/jbc.M112.386904

  • CrossRef
  • Google Scholar

• 18

  CarlsonJ. H.HughesS.HoganD.CieplakG.SturdevantD. E.McClartyG.et al. (2004). Polymorphisms in the chlamydia trachomatis cytotoxin locus associated with ocular and genital isolates. Infect. Immun.72 (12), 7063–7072. doi: 10.1128/IAI.72.12.7063-7072.2004

  • CrossRef
  • Google Scholar

• 19

  CarlsonJ. H.WhitmireW. M.CraneD. D.WickeL.VirtanevaK.SturdevantD. E.et al. (2008). The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor. Infect. Immun.76 (6), 2273–2283. doi: 10.1128/iai.00102-08

  • CrossRef
  • Google Scholar

• 20

  CarlsonJ. H.WoodH.RoshickC.CaldwellH. D.McClartyG. (2006). In vivo and in vitro studies of Chlamydia trachomatis TrpR: DNA interactions. Mol. Microbiol.59 (6), 1678–1691. doi: 10.1111/j.1365-2958.2006.05045.x

  • CrossRef
  • Google Scholar

• 21

  CarpenterV.ChenY.-S.DolatL.ValdiviaR. H. (2017). The effector tepP mediates recruitment and activation of phosphoinositide 3-kinase on early chlamydia trachomatis vacuoles. mSphere2 (4), e00207–17. doi: 10.1128/mSphere.00207-17

  • CrossRef
  • Google Scholar

• 22

  CarrascoJ. A.TanC.RankR. G.HsiaR.c.BavoilP. M. (2011). Altered developmental expression of polymorphic membrane proteins in penicillin-stressed Chlamydia trachomatis. Cell. Microbiol.13 (7), 1014–1025. doi: 10.1111/j.1462-5822.2011.01598.x

  • CrossRef
  • Google Scholar

• 23

  CaseE. D. R.AkersJ. C.TanM. (2011). CT406 encodes a chlamydial ortholog of nrdR, a repressor of ribonucleotide reductase. J. Bacteriol.193 (17), 4396–4404. doi: 10.1128/JB.00294-11

  • CrossRef
  • Google Scholar

• 24

  ChenA. L.JohnsonK. A.LeeJ. K.SütterlinC.TanM. (2012). CPAF: a Chlamydial protease in search of an authentic substrate. PLoS Pathog. (8), e1002842. doi: 10.1371/journal.ppat.1002842

  • CrossRef
  • Google Scholar

• 25

  ChenY.-S.BastidasR. J.SakaH. A.CarpenterV. K.RichardsK. L.PlanoG. V.et al. (2014). The chlamydia trachomatis type III secretion chaperone slc1 engages multiple early effectors, including tepP, a tyrosine-phosphorylated protein required for the recruitment of crkI-II to nascent inclusions and innate immune signaling. PloS Pathog.10 (2), e1003954. doi: 10.1371/journal.ppat.1003954

  • CrossRef
  • Google Scholar

• 26

  ChenH.WenY.LiZ. (2019). Clear victory for chlamydia : the subversion of host innate immunity. Front. Microbiol.10. doi: 10.3389/fmicb.2019.01412

  • CrossRef
  • Google Scholar

• 27

  ChuJ.LiX.QuG.WangY.LiQ.GuoY.et al. (2020). Chlamydia psittaci pmpD-N exacerbated chicken macrophage function by triggering th2 polarization and the TLR2/myD88/NF-κB signaling pathway. Int. J. Mol. Sci.21 (6), 2003. doi: 10.3390/ijms21062003

  • CrossRef
  • Google Scholar

• 28

  CingolaniG.McCauleyM.LobleyA.BryerA. J.WesolowskiJ.GrecoD. L.et al. (2019). Structural basis for the homotypic fusion of chlamydial inclusions by the SNARE-like protein IncA. Nat. Commun.10 (1), 2747–2712. doi: 10.1038/s41467-019-10806-9

  • CrossRef
  • Google Scholar

• 29

  CliftonD. R.DooleyC. A.GrieshaberS. S.CarabeoR. A.FieldsK. A.HackstadtT. (2005). Tyrosine phosphorylation of the chlamydial effector protein Tarp is species specific and not required for recruitment of actin. Infect. Immun.73 (7), 3860–3868. doi: 10.1128/IAI.73.7.3860-3868.2005

  • CrossRef
  • Google Scholar

• 30

  CliftonD. R.FieldsK. A.GrieshaberS. S.DooleyC. A.FischerE. R.MeadD. J.et al. (2004). A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc. Natl. Acad. Sci.101 (27), 10166–10171. doi: 10.1073/pnas.0402829101

  • CrossRef
  • Google Scholar

• 31

  CoburnB.SekirovI.FinlayB. B. (2007). Type III secretion systems and disease. Clin. Microbiol. Rev.20 (4), 535–549. doi: 10.1128/CMR.00013-07

  • CrossRef
  • Google Scholar

• 32

  da CunhaM.PaisS. V.BugalhãoJ. N.MotaL. J. (2017). The Chlamydia trachomatis type III secretion substrates CT142, CT143, and CT144 are secreted into the lumen of the inclusion. PloS One12 (6), e0178856–e0178856. doi: 10.1371/journal.pone.0178856

  • CrossRef
  • Google Scholar

• 33

  DaviesB.TurnerK. M.FrølundM.WardH.MayM. T.RasmussenS.et al. (2016). Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark. Lancet Infect. Dis.16 (9), 1057–1064. doi: 10.1016/S1473-3099(16)30092-5

  • CrossRef
  • Google Scholar

• 34

  DehouxP.FloresR.DaugaC.ZhongG.SubtilA. (2011). Multi-genome identification and characterization of chlamydiae-specific type III secretion substrates: the Inc proteins. BMC Genomics12 (1), 109–109. doi: 10.1186/1471-2164-12-109

  • CrossRef
  • Google Scholar

• 35

  DirksJ. A. M. C.JanssenK.HoebeC. J. P. A.GeelenT. H. B.LucchesiM.Dukers-MuijrersN. H. T. M.et al. (2021). Chlamydia trachomatis intra-bacterial and total plasmid copy number in clinical urogenital samples. Sci. Rep.11 (1), 259–256. doi: 10.1038/s41598-020-80645-y

  • CrossRef
  • Google Scholar

• 36

  DolatL.ValdiviaR. H. (2021). An endometrial organoid model of interactions between Chlamydia and epithelial and immune cells. J. Cell Sci.134 (5), jcs252403. doi: 10.1242/jcs.252403

  • CrossRef
  • Google Scholar

• 37

  DumouxM.MennyA.DelacourD.HaywardR. D. (2015). A Chlamydia effector recruits CEP170 to reprogram host microtubule organization. J. Cell Sci.128 (18), 3420–3434. doi: 10.1242/jcs.169318

  • CrossRef
  • Google Scholar

• 38

  ElwellC.MirrashidiK.EngelJ. (2016). Chlamydia cell biology and pathogenesis. Nat. Rev. Microbiol.14 (6), 385–400. doi: 10.1038/nrmicro.2016.30

  • CrossRef
  • Google Scholar

• 39

  FarisR.McCulloughA.AndersenS. E.MoningerT. O.WeberM. M. (2020). The Chlamydia trachomatis secreted effector TmeA hijacks the N-WASP-ARP2/3 actin remodeling axis to facilitate cellular invasion. PloS Pathog.16 (9), e1008878–e1008878. doi: 10.1371/journal.ppat.1008878

  • CrossRef
  • Google Scholar

• 40

  FieldsK. A.BoderoM. D.ScanlonK. R.JewettT. J.WolfK.. (2022). A minimal replicon enables efficacious, species-specific gene deletion in chlamydia and extension of gene knockout studies to the animal model of infection using chlamydia muridarum. Infect. Immun.90 (12), e0045322. doi: 10.1128/iai.00453-22

  • CrossRef
  • Google Scholar

• 41

  FischerA.HarrisonK. S.RamirezY.AuerD.ChowdhuryS. R.PrustyB. K.et al. (2017). Chlamydia trachomatis -containing vacuole serves as deubiquitination platform to stabilize Mcl-1 and to interfere with host defense. eLife6, e21465. doi: 10.7554/eLife.21465

  • CrossRef
  • Google Scholar

• 42

  FisherD. J.BeareP. A. (2023). Recent advances in genetic systems in obligate intracellular human-pathogenic bacteria. Front. Cell. Infect. Microbiol.13. doi: 10.3389/fcimb.2023.1202245

  • CrossRef
  • Google Scholar

• 43

  GaoL.CongY.PlanoG. V.RaoX.GisclairL. N.Schesser BartraS.et al. (2020). Context-dependent action of scc4 reinforces control of the type III secretion system. J. Bacteriol.202 (15), 1. doi: 10.1128/JB.00132-20

  • CrossRef
  • Google Scholar

• 44

  GehreL.GorgetteO.PerrinetS.PrevostM.-C.DucatezM.GiebelA. M.et al. (2016). Sequestration of host metabolism by an intracellular pathogen. eLife5, e12552–e12552. doi: 10.7554/eLife.12552

  • CrossRef
  • Google Scholar

• 45

  GeislerW. M. (2010). Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies. J. Infect. Dis.201 Suppl 2, S104–S113. doi: 10.1086/652402

  • CrossRef
  • Google Scholar

• 46

  GitselsA.SandersN.VanrompayD. (2019). Chlamydial infection from outside to inside. Front. Microbiol.10 (2329). doi: 10.3389/fmicb.2019.02329

  • CrossRef
  • Google Scholar

• 47

  GloecklS.OngV. A.PatelP.TyndallJ. D.TimmsP.BeagleyK. W.et al. (2013). Identification of a serine protease inhibitor which causes inclusion vacuole reduction and is lethal to Chlamydia trachomatis. Mol. Microbiol.89 (4), 676–689. doi: 10.1111/mmi.12306

  • CrossRef
  • Google Scholar

• 48

  GhoshS.RuelkeE. A.FerrellJ. C.BoderoM. D.FieldsK. A.JewettT. J. (2020). Fluorescence-reported allelic exchange mutagenesis-mediated gene deletion indicates a requirement for chlamydia trachomatis tarp during in vivo infectivity and reveals a specific role for the C terminus during cellular invasion. Infect. Immun.88 (5), e00841–19. doi: 10.1128/IAI.00841-19

  • CrossRef
  • Google Scholar

• 49

  GomesJ. P.NunesA.BrunoW. J.BorregoM. J.FlorindoC.DeanD. (2006). Polymorphisms in the Nine Polymorphic Membrane Proteins of Chlamydia trachomatis across All Serovars: Evidence for Serovar Da Recombination and Correlation with Tissue Tropism. J. Bacteriol.188 (1), 275–286. doi: 10.1128/JB.188.1.275-286.2006

  • CrossRef
  • Google Scholar

• 50

  GuifengS. U. N.PalS.SarconA. K.KimS.SugawaraE.NikaidoH.et al. (2007). Structural and functional analyses of the major outer membrane protein of chlamydia trachomatis. J. Bacteriol.189 (17), 6222–6235. doi: 10.1128/JB.00552-07

  • CrossRef
  • Google Scholar

• 51

  HafnerL.BeagleyK.TimmsP. (2008). Chlamydia trachomatis infection: host immune responses and potential vaccines. Mucosal Immunol.1 (2), 116–130. doi: 10.1038/mi.2007.19

  • CrossRef
  • Google Scholar

• 52

  HansonB. R.SlepenkinA.PetersonE. M.TanM. (2015). Chlamydia trachomatis type III secretion proteins regulate transcription. J. Bacteriol.197 (20), 3238–3244. doi: 10.1128/JB.00379-15

  • CrossRef
  • Google Scholar

• 53

  HatchN. D.OuelletteS. P. (2023). Identification of the alternative sigma factor regulons of Chlamydia trachomatis using multiplexed CRISPR interference. mSphere, e0039123. doi: 10.1128/msphere.00391-23

  • CrossRef
  • Google Scholar

• 54

  HeplerR. W.NahasD. D.LucasB.KaufholdR.FlynnJ. A.GalliJ. D.et al. (2018). Spectroscopic analysis of chlamydial major outer membrane protein in support of structure elucidation: Biophysical Characterization of MOMP. Protein Sci.27 (11), 1923–1941. doi: 10.1002/pro.3501

  • CrossRef
  • Google Scholar

• 55

  HogerwerfL.RoofI.de JongM. J. K.DijkstraF.van der HoekW. (2020). Animal sources for zoonotic transmission of psittacosis: a systematic review. BMC Infect. Dis.20 (1), 192–192. doi: 10.1186/s12879-020-4918-y

  • CrossRef
  • Google Scholar

• 56

  HuangY.WurihanW.LuB.ZouY.WangY.WeldonK.et al. (2022). Robust heat shock response in chlamydia lacking a typical heat shock sigma factor. Front. Microbiol.12. doi: 10.3389/fmicb.2021.812448

  • CrossRef
  • Google Scholar

• 57

  HustonW. M.SwedbergJ. E.HarrisJ. M.WalshT. P.MathewsS. A.TimmsP. (2007). The temperature activated HtrA protease from pathogen Chlamydia trachomatis acts as both a chaperone and protease at 37°C. FEBS Lett.581 (18), 3382–3386. doi: 10.1016/j.febslet.2007.06.039

  • CrossRef
  • Google Scholar

• 58

  HustonW. M.TheodoropoulosC.MathewsS. A.TimmsP. (2008). Chlamydia trachomatis responds to heat shock, penicillin induced persistence, and IFN-gamma persistence by altering levels of the extracytoplasmic stress response protease HtrA. BMC Microbiol.8 (1), 190–190. doi: 10.1186/1471-2180-8-190

  • CrossRef
  • Google Scholar

• 59

  JorgensenI.ValdiviaR. H. (2008). Pmp-Like Proteins Pls1 and Pls2 Are Secreted into the Lumen of the Chlamydia trachomatis Inclusion. Infect. Immun.76 (9), 3940–3950. doi: 10.1128/IAI.00632-08

  • CrossRef
  • Google Scholar

• 60

  KariL.SouthernT. R.DowneyC. J.WatkinsH. S.RandallL. B.TaylorL. D.et al. (2014). Chlamydia trachomatis polymorphic membrane protein D is a virulence factor involved in early host-cell interactions. Infect. Immun.82 (7), 2756–2762. doi: 10.1128/IAI.01686-14

  • CrossRef
  • Google Scholar

• 61

  KiselevA. O.SkinnerM. C.LampeM. F. (2009). Analysis of pmpD expression and PmpD post-translational processing during the life cycle of Chlamydia trachomatis serovars A, D, and L2. PloS One4 (4), e5191–e5191. doi: 10.1371/journal.pone.0005191

  • CrossRef
  • Google Scholar

• 62

  KolbergM.StrandK. R.GraffP.Kristoffer AnderssonK. (2004). Structure, function, and mechanism of ribonucleotide reductases. BBA - Proteins Proteomics1699 (1), 1–34. doi: 10.1016/j.bbapap.2004.02.007

  • CrossRef
  • Google Scholar

• 63

  KooI. C.StephensR. S. (2003). A developmentally regulated two-component signal transduction system in chlamydia. J. Biol. Chem.278 (19), 17314–17319. doi: 10.1074/jbc.M212170200

  • CrossRef
  • Google Scholar

• 64

  KooI. C.WalthersD.HeftyP. S.KenneyL. J.StephensR. S. (2006). ChxR is a transcriptional activator in chlamydia. Proc. Natl. Acad. Sci. - PNAS103 (3), 750–755. doi: 10.1073/pnas.0509690103

  • CrossRef
  • Google Scholar

• 65

  LaBrieS. D.DimondZ. E.HarrisonK. S.BaidS.WickstrumJ.SuchlandR. J.et al. (2019). Transposon mutagenesis in chlamydia trachomatis identifies CT339 as a comEC homolog important for DNA uptake and lateral gene transfer. mBio10 (4), e01343–19. doi: 10.1128/mBio.01343-19

  • CrossRef
  • Google Scholar

• 66

  LaneB. J.MutchlerC.Al KhodorS.GrieshaberS. S.CarabeoR. A. (2008). Chlamydial entry involves TARP binding of guanine nucleotide exchange factors. PloS Pathog.4 (3), e1000014. doi: 10.1371/journal.ppat.1000014

  • CrossRef
  • Google Scholar

• 67

  LawrenceA.FraserT.GillettA.TyndallJ. D. A.TimmsP.PolkinghorneA.et al. (2016). Chlamydia Serine Protease Inhibitor, targeting HtrA, as a New Treatment for Koala Chlamydia infection. Sci. Rep.6 (1), 31466. doi: 10.1038/srep31466

  • CrossRef
  • Google Scholar

• 68

  LeiL.YangC.PattonM. J.SmelkinsonM.DorwardD.MaL.et al. (2021). A chlamydial plasmid-dependent secretion system for the delivery of virulence factors to the host cytosol. mBio12 (3), e0117921–e0117921. doi: 10.1128/mBio.01179-21

  • CrossRef
  • Google Scholar

• 69

  LiZ.DouglasA. L.HatchT. P. (1998). Characterization of a Chlamydia psittaci DNA binding protein (EUO) synthesized during the early and middle phases of the developmental cycle. Infect. Immun.66 (3), 1167–1173. doi: 10.1128/iai.66.3.1167-1173.1998

  • CrossRef
  • Google Scholar

• 70

  LuísM. P.PereiraI. S.BugalhãoJ. N.SimõesC. N.MotaC.RomãoM. J.et al. (2023). The chlamydia trachomatis incM protein interferes with host cell cytokinesis, centrosome positioning, and golgi distribution and contributes to the stability of the pathogen-containing vacuole. Infect. Immun.91 (4), e0040522–e0040522. doi: 10.1128/iai.00405-22

  • CrossRef
  • Google Scholar

• 71

  LuuL. D. W.KasimovV.PhillipsS.MyersG. S.JelocnikM. (2023). Genome organization and genomics in Chlamydia: whole genome sequencing increases understanding of chlamydial virulence, evolution, and phylogeny. Front. Cell. Infect. Microbiol.13, 1178736. doi: 10.3389/fcimb.2023.1178736

  • CrossRef
  • Google Scholar

• 72

  MandelC.YangH.BuchkoG. W.AbendrothJ.GrieshaberN.ChiarelliT.et al. (2022). Expression and structure of the Chlamydia trachomatis DksA ortholog. Pathog. Dis.80 (1), ftac007. doi: 10.1093/femspd/ftac007

  • CrossRef
  • Google Scholar

• 73

  MathewsS. A.VolpK. M.TimmsP. (1999). Development of a quantitative gene expression assay for Chlamydia trachomatis identified temporal expression of σ factors. FEBS Lett.458 (3), 354–358. doi: 10.1016/S0014-5793(99)01182-5

  • CrossRef
  • Google Scholar

• 74

  McClartyG.CaldwellH. D.NelsonD. E. (2006). Chlamydial interferon gamma immune evasion influences infection tropism. Curr. Opin. Microbiol.10 (1), 47–51. doi: 10.1016/j.mib.2006.12.003

  • CrossRef
  • Google Scholar

• 75

  McKuenM. J.MuellerK. E.BaeY. S.FieldsK. A. (2017). Fluorescence-reported allelic exchange mutagenesis reveals a role for chlamydia trachomatis tmeA in invasion that is independent of host AHNAK. Infect. Immun.85 (12), e00640–17. doi: 10.1128/IAI.00640-17

  • CrossRef
  • Google Scholar

• 76

  MeierK.JachmannL. H.TürközG.Babu SaitM. R.PérezL.KeppO.et al. (2023). The Chlamydia effector CpoS modulates the inclusion microenvironment and restricts the interferon response by acting on Rab35. mBio14 (4), e0319022. doi: 10.1128/mbio.03190-22

  • CrossRef
  • Google Scholar

• 77

  MenonS.TimmsP.AllanJ. A.AlexanderK.RombautsL.HornerP.et al. (2015). Human and pathogen factors associated with chlamydia trachomatis-related infertility in women. Clin. Microbiol. Rev.28 (4), 969–985. doi: 10.1128/CMR.00035-15

  • CrossRef
  • Google Scholar

• 78

  MishkinN.Ricart ArbonaR. J.CarrascoS. E.LawtonS.HendersonK. S.MomtsiosP.et al. (2022). Reemergence of the murine bacterial pathogen chlamydia muridarum in research mouse colonies. Comp. Med.72 (4), 230–242. doi: 10.30802/AALAS-CM-22-000045

  • CrossRef
  • Google Scholar

• 79

  MitalJ.LutterE. I.BargerA. C.DooleyC. A.HackstadtT. (2015). Chlamydia trachomatis inclusion membrane protein CT850 interacts with the dynein light chain DYNLT1 (Tctex1). Biochem. Biophys. Res. Commun.462 (2), 165–170. doi: 10.1016/j.bbrc.2015.04.116

  • CrossRef
  • Google Scholar

• 80

  MitalJ.MillerN. J.DorwardD. W.DooleyC. A.HackstadtT. (2013). Role for chlamydial inclusion membrane proteins in inclusion membrane structure and biogenesis. PloS One8 (5), e63426–e63426. doi: 10.1371/journal.pone.0063426

  • CrossRef
  • Google Scholar

• 81

  MuellerK. E.FieldsK. A. (2015). Application of β-lactamase reporter fusions as an indicator of effector protein secretion during infections with the obligate intracellular pathogen Chlamydia trachomatis. PloS One10 (8), e0135295–e0135295. doi: 10.1371/journal.pone.0135295

  • CrossRef
  • Google Scholar

• 82

  MuellerK. E.PlanoG. V.FieldsK. A. (2014). New frontiers in type III secretion biology: the Chlamydia perspective. Infect. Immun.82 (1), 2–9. doi: 10.1128/IAI.00917-13

  • CrossRef
  • Google Scholar

• 83

  MuellerK. E.WolfK.FieldsK. A. (2016). Gene deletion by fluorescence-reported allelic exchange mutagenesis in chlamydia trachomatis. mBio7 (1), e01817–e01815. doi: 10.1128/mBio.01817-15

  • CrossRef
  • Google Scholar

• 84

  MurrayS. M.McKayP. F. (2021). Chlamydia trachomatis: Cell biology, immunology and vaccination. Vaccine39 (22), 2965–2975. doi: 10.1016/j.vaccine.2021.03.043

  • CrossRef
  • Google Scholar

• 85

  MurthyA. K.LiW.RamseyK. H. (2018). Immunopathogenesis of chlamydial infections. Curr. topics Microbiol. Immunol.412, 183–215. doi: 10.1007/82_2016_18

  • CrossRef
  • Google Scholar

• 86

  NewmanL.RowleyJ.Vander HoornS.WijesooriyaN. S.UnemoM.LowN.et al. (2015). Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PloS One10 (12), e0143304–e0143304. doi: 10.1371/journal.pone.0143304

  • CrossRef
  • Google Scholar

• 87

  NguyenP. H.LutterE. I.HackstadtT. (2018). Chlamydia trachomatis inclusion membrane protein MrcA interacts with the inositol 1,4,5-trisphosphate receptor type 3 (ITPR3) to regulate extrusion formation. PloS Pathog.14 (3), e1006911. doi: 10.1371/journal.ppat.1006911

  • CrossRef
  • Google Scholar

• 88

  NicholsonT. L.OlingerL.ChongK.SchoolnikG.StephensR. S. (2003). Global Stage-Specific Gene Regulation during the Developmental Cycle of Chlamydia trachomatis. J. Bacteriol.185 (10), 3179–3189. doi: 10.1128/JB.185.10.3179-3189.2003

  • CrossRef
  • Google Scholar

• 89

  NunesA.GomesJ. P.MeadS.FlorindoC.CorreiaH.BorregoM. J.et al. (2007). Comparative expression profiling of the Chlamydia trachomatis pmp gene family for clinical and reference strains. PloS One2 (9), e878–e878. doi: 10.1371/journal.pone.0000878

  • CrossRef
  • Google Scholar

• 90

  O'NeillC. E.SkiltonR. J.ForsterJ.ClearyD. W.PearsonS. A.LampeD. J.et al. (2021). An inducible transposon mutagenesis approach for the intracellular human pathogen Chlamydia trachomatis. Wellcome Open Res.6, 312. doi: 10.12688/wellcomeopenres.16068.1

  • CrossRef
  • Google Scholar

• 91

  Olson-WoodM. G.JorgensonL. M.OuelletteS. P.RucksE. A. (2021). Inclusion membrane growth and composition are altered by overexpression of specific inclusion membrane proteins in chlamydia trachomatis L2. Infect. Immun.89 (7), e0009421–e0009421. doi: 10.1128/IAI.00094-21

  • CrossRef
  • Google Scholar

• 92

  OngV. A.MarshJ. W.LawrenceA.AllanJ. A.TimmsP.HustonW. M. (2013). The protease inhibitor JO146 demonstrates a critical role for CtHtrA for Chlamydia trachomatis reversion from penicillin persistence. Front. Cell. Infect. Microbiol.3. doi: 10.3389/fcimb.2013.00100

  • CrossRef
  • Google Scholar

• 93

  OuelletteS. P. (2018). Feasibility of a conditional knockout system for chlamydia based on CRISPR interference. Front. Cell. Infect. Microbiol.8. doi: 10.3389/fcimb.2018.00059

  • CrossRef
  • Google Scholar

• 94

  OuelletteS. P.BlayE. A.HatchN. D.Fisher-MarvinL. A. (2021). CRISPR interference to inducibly repress gene expression in chlamydia trachomatis. Infect. Immun.89 (7), e0010821. doi: 10.1128/iai.00108-21

  • CrossRef
  • Google Scholar

• 95

  PaisS. V.KeyC. E.BorgesV.PereiraI. S.GomesJ. P.FisherD. J.et al. (2019). CteG is a Chlamydia trachomatis effector protein that associates with the Golgi complex of infected host cells. Sci. Rep.9 (1), 6133–6133. doi: 10.1038/s41598-019-42647-3

  • CrossRef
  • Google Scholar

• 96

  PanzettaM. E.LujánA. L.BastidasR. J.DamianiM. T.ValdiviaR. H.SakaH. A. (2019). Ptr/CTL0175 is required for the efficient recovery of chlamydia trachomatis from stress induced by gamma-interferon. Front. Microbiol.10. doi: 10.3389/fmicb.2019.00756

  • CrossRef
  • Google Scholar

• 97

  PanzettaM. E.ValdiviaR. H.SakaH. A. (2018). Chlamydia persistence: A survival strategy to evade antimicrobial effects in-vitro and in-vivo. Front. Microbiol.9. doi: 10.3389/fmicb.2018.03101

  • CrossRef
  • Google Scholar

• 98

  PatelP.De BoerL.TimmsP.HustonW. M. (2014). Evidence of a conserved role for Chlamydia HtrA in the replication phase of the chlamydial developmental cycle. Microbes infection16 (8), 690–694. doi: 10.1016/j.micinf.2014.07.003

  • CrossRef
  • Google Scholar

• 99

  PaumetF.WesolowskiJ.Garcia-DiazA.DelevoyeC.AulnerN.ShumanH. A.et al. (2009). Intracellular bacteria encode inhibitory SNARE-like proteins. PloS One4 (10), e7375.

  • Google Scholar

• 100

  PedrosaA. T.MurphyK. N.NogueiraA. T.BrinkworthA. J.ThwaitesT. R.AaronJ.et al. (2020). A post-invasion role for Chlamydia type III effector TarP in modulating the dynamics and organization of host cell focal adhesions. J. Biol. Chem.295 (43), 14763–14779. doi: 10.1074/jbc.RA120.015219

  • CrossRef
  • Google Scholar

• 101

  PenniniM. E.PerrinetS.Dautry-VarsatA.SubtilA. (2010). Histone methylation by NUE, a novel nuclear effector of the intracellular pathogen Chlamydia trachomatis. PloS Pathog.6 (7), e1000995–e1000995. doi: 10.1371/journal.ppat.1000995

  • CrossRef
  • Google Scholar

• 102

  PokorzynskiN. D.BrinkworthA. J.CarabeoR. (2019). A bipartite iron-dependent transcriptional regulation of the tryptophan salvage pathway in Chlamydia trachomatis. eLife8, e42295. doi: 10.7554/eLife.42295

  • CrossRef
  • Google Scholar

• 103

  PrunedaJ. N.BastidasR. J.BertsoulakiE.SwatekK. N.SanthanamB.ClagueM. J.et al. (2018). A Chlamydia effector combining deubiquitination and acetylation activities induces Golgi fragmentation. Nat. Microbiol.3 (12), 1377–1384. doi: 10.1038/s41564-018-0271-y

  • CrossRef
  • Google Scholar

• 104

  QuY.FrazerL. C.O'ConnellC. M.TarantalA. F.AndrewsJ. C. W.O'ConnorS. L.et al. (2015). Comparable genital tract infection, pathology, and immunity in rhesus macaques inoculated with wild-type or plasmid-deficient chlamydia trachomatis serovar D. Infect. Immun.83 (10), 4056–4067. doi: 10.1128/IAI.00841-1510.1128/IAI.00841-15

  • CrossRef
  • Google Scholar

• 105

  RajeeveK.DasS.PrustyB. K.RudelT. (2018). Chlamydia trachomatis paralyses neutrophils to evade the host innate immune response. Nat. Microbiol.3 (7), 824–835. doi: 10.1038/s41564-018-0182-y

  • CrossRef
  • Google Scholar

• 106

  RaoX.DeighanP.HuaZ.HuX.WangJ.LuoM.et al. (2009). A regulator from Chlamydia trachomatis modulates the activity of RNA polymerase through direct interaction with the beta subunit and the primary sigma subunit. Genes Dev.23 (15), 1818–1829. doi: 10.1101/gad.1784009

  • CrossRef
  • Google Scholar

• 107

  ReadT. D.MasseyR. C. (2014). Characterizing the genetic basis of bacterial phenotypes using genome-wide association studies: A new direction for Bacteriol. Genome Med.6 (11), 109–109. doi: 10.1186/s13073-014-0109-z

  • CrossRef
  • Google Scholar

• 108

  RzompK. A.MoorheadA. R.ScidmoreM. A. (2006). The GTPase rab4 interacts with chlamydia trachomatis inclusion membrane protein CT229. Infect. Immun.74 (9), 5362–5373. doi: 10.1128/IAI.00539-06

  • CrossRef
  • Google Scholar

• 109

  SahP.LutterE. I. (2020). Hijacking and use of host kinases by chlamydiae. Pathogens9 (12), 1034. doi: 10.3390/pathogens9121034

  • CrossRef
  • Google Scholar

• 110

  SakaH. A.ThompsonJ. W.ChenY.-S.KumarY.DuboisL. G.MoseleyM. A.et al. (2011). Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms: Quantitative proteomics analysis of C. trachomatis developmental forms. Mol. Microbiol.82 (5), 1185–1203. doi: 10.1111/j.1365-2958.2011.07877.x

  • CrossRef
  • Google Scholar

• 111

  ScanlonK. R.KebG.WolfK.JewettT. J.FieldsK. A. (2023). Chlamydia trachomatis TmeB antagonizes actin polymerization via direct interference with Arp2/3 activity. Front. Cell. Infect. Microbiol.13. doi: 10.3389/fcimb.2023.1232391

  • CrossRef
  • Google Scholar

• 112

  SchaumburgC. S.TanM. (2006). Arginine-dependent gene regulation via the argR repressor is species specific in chlamydia. J. Bacteriol.188 (3), 919–927. doi: 10.1128/JB.188.3.919-927.2006

  • CrossRef
  • Google Scholar

• 113

  SchoborgR. V. (2011). Chlamydia persistence – a tool to dissect chlamydia–host interactions. Microbes infection13 (7), 649–662. doi: 10.1016/j.micinf.2011.03.004

  • CrossRef
  • Google Scholar

• 114

  ScidmoreM. A. (2009). "Chlamydia," in Encyclopedia of Microbiology (Third Edition). Ed. SchaechterM. (Oxford: Academic Press), 74–86.

  • Google Scholar

• 115

  ScidmoreM.HackstadtT. (2001). Mammalian 14-3-3β associates with the chlamydia trachomatis inclusion membrane via its interaction with IncG. Mol. Microbiol.39 (6), 1638–1650.

  • Google Scholar

• 116

  ShehatM. G.AranjuezG. F.KimJ.JewettT. J. (2021). The Chlamydia trachomatis Tarp effector targets the Hippo pathway. Biochem. Biophys. Res. Commun.562, 133–138. doi: 10.1016/j.bbrc.2021.05.057

  • CrossRef
  • Google Scholar

• 117

  SixtB. S.BastidasR. J.FinethyR.BaxterR. M.CarpenterV. K.KroemerG.et al. (2017). The chlamydia trachomatis inclusion membrane protein cpoS counteracts STING-mediated cellular surveillance and suicide programs. Cell Host Microbe21 (1), 113–121. doi: 10.1016/j.chom.2016.12.002

  • CrossRef
  • Google Scholar

• 118

  ShawE.DooleyC.FischerE.ScidmoreM.FieldsK.HackstadtT. (2000). Three temporal classes of gene expression during the chlamydia trachomatis developmental cycle. Mol. Microbiol.37 (4), 913–925.

  • Google Scholar

• 119

  SnavelyE. A.KokesM.DunnJ. D.SakaH. A.NguyenB. D.BastidasR. J.et al. (2014). Reassessing the role of the secreted protease CPAF in Chlamydia trachomatis infection through genetic approaches. Pathog. Dis.71 (3), 336–351. doi: 10.1111/2049-632X.12179

  • CrossRef
  • Google Scholar

• 120

  SongL.CarlsonJ. H.WhitmireW. M.KariL.VirtanevaK.SturdevantD. E.et al. (2013). Chlamydia trachomatis plasmid-encoded pgp4 is a transcriptional regulator of virulence-associated genes. Infect. Immun.81 (3), 636–644. doi: 10.1128/IAI.01305-12

  • CrossRef
  • Google Scholar

• 121

  SoulesK. R.LaBrieS. D.MayB. H.HeftyP. S. (2020). Sigma 54-Regulated Transcription Is Associated with Membrane Reorganization and Type III Secretion Effectors during Conversion to Infectious Forms of Chlamydia trachomatis. mBio11 (5), e01725–20. doi: 10.1128/mBio.01725-20

  • CrossRef
  • Google Scholar

• 122

  StallmannS.HegemannJ. H. (2016). The Chlamydia trachomatis Ctad1 invasin exploits the human integrin β1 receptor for host cell entry: Chlamydia trachomatis Ctad1 binds to integrin β1. Cell. Microbiol.18 (5), 761–775. doi: 10.1111/cmi.12549

  • CrossRef
  • Google Scholar

• 123

  StanhopeR.DerréI. (2018). Making contact: VAP targeting by intracellular pathogens. Contact1, 251525641877551. doi: 10.1177/2515256418775512

  • CrossRef
  • Google Scholar

• 124

  StanhopeR.FloraE.BayneC.DerréI. (2017). IncV, a FFAT motif-containing Chlamydia protein, tethers the endoplasmic reticulum to the pathogen-containing vacuole. Proc. Natl. Acad. Sci.114 (45), 12039–12044. doi: 10.1073/pnas.1709060114

  • CrossRef
  • Google Scholar

• 125

  SteiertB.IcardiC. M.FarisR.McCaslinP. N.SmithP.KlingelhutzA. J.et al. (2023). The Chlamydia trachomatis type III-secreted effector protein CteG induces centrosome amplification through interactions with centrin-2. Proc. Natl. Acad. Sci.120 (20), e2303487120. doi: 10.1073/pnas.2303487120

  • CrossRef
  • Google Scholar

• 126

  StephensR. S.KalmanS.LammelC.FanJ.MaratheR.AravindL.et al. (1998). Genome sequence of an obligate intracellular pathogen of humans: chlamydia trachomatis. Science282 (5389), 754–759. doi: 10.1126/science.282.5389.754

  • CrossRef
  • Google Scholar

• 127

  SuchlandR. J.RockeyD. D.BannantineJ. P.StammW. E. (2000). Isolates of chlamydia trachomatis that occupy nonfusogenic inclusions lack incA, a protein localized to the inclusion membrane. Infect. Immun.68 (1), 360–367. doi: 10.1128/IAI.68.1.360-367.2000

  • CrossRef
  • Google Scholar

• 128

  SwansonK. A.TaylorL. D.FrankS. D.SturdevantG. L.FischerE. R.CarlsonJ. H.et al. (2009). Chlamydia trachomatis polymorphic membrane protein D is an oligomeric autotransporter with a higher-order structure. Infect. Immun.77 (1), 508–516. doi: 10.1128/IAI.01173-08

  • CrossRef
  • Google Scholar

• 129

  SwobodaA. R.WoodN. A.SaeryE. A.FisherD. J.OuelletteS. P. (2023). The periplasmic tail-specific protease, tsp, is essential for secondary differentiation in chlamydia trachomatis. J. Bacteriol.205 (5), e0009923–e0009923. doi: 10.1128/jb.00099-23

  • CrossRef
  • Google Scholar

• 130

  TanC.HsiaR.-c.ShouH.CarrascoJ. A.RankR. G.BavoilP. M. (2010). Variable expression of surface-exposed polymorphic membrane proteins in in vitro-grown Chlamydia trachomatis. Cell. Microbiol.12 (2), 174–187. doi: 10.1111/j.1462-5822.2009.01389.x

  • CrossRef
  • Google Scholar

• 131

  TanC.HsiaR.-c.ShouH.HaggertyC. L.NessR. B.GaydosC. A.et al. (2009). Chlamydia trachomatis-infected patients display variable antibody profiles against the nine-member polymorphic membrane protein family. Infect. Immun.77 (8), 3218–3226. doi: 10.1128/IAI.01566-08

  • CrossRef
  • Google Scholar

• 132

  TaylorH. R.BurtonM. J.HaddadD.WestS.WrightH. (2014). Trachoma. Lancet384 (9960), 2142–2152. doi: 10.1016/S0140-6736(13)62182-0

  • CrossRef
  • Google Scholar

• 133

  ThalmannJ.JanikK.MayM.SommerK.EbelingJ.HofmannF.et al. (2010). Actin re-organization induced by Chlamydia trachomatis serovar D–evidence for a critical role of the effector protein CT166 targeting Rac. PloS One5 (3), e9887–e9887. doi: 10.1371/journal.pone.0009887

  • CrossRef
  • Google Scholar

• 134

  ThompsonC. C.GriffithsC.NicodS. S.LowdenN. M.WigneshwerarajS.FisherD. J.et al. (2015). The Rsb Phosphoregulatory Network Controls Availability of the Primary Sigma Factor in Chlamydia trachomatis and Influences the Kinetics of Growth and Development. PloS Pathog.11 (8), e1005125. doi: 10.1371/journal.ppat.1005125

  • CrossRef
  • Google Scholar

• 135

  ThompsonC. C.NicodS. S.MalcolmD. S.GrieshaberS. S.CarabeoR. A. (2012). Cleavage of a putative metal permease in Chlamydia trachomatis yields an iron-dependent transcriptional repressor. Proc. Natl. Acad. Sci. - PNAS109 (26), 10546–10551. doi: 10.1073/pnas.1201398109

  • CrossRef
  • Google Scholar

• 136

  ThwaitesT. R.PedrosaA. T.PeacockT. P.CarabeoR. A. (2015). Vinculin interacts with the Chlamydia effector TarP via a tripartite vinculin binding domain to mediate actin recruitment and assembly at the plasma membrane. Front. Cell. Infect. Microbiol.5, 88. doi: 10.3389/fcimb.2015.00088

  • CrossRef
  • Google Scholar

• 137

  TurmanB. J.DarvilleT.O'ConnellC. M. (2023). Plasmid-mediated virulence in chlamydia. Front. Cell. Infect. Microbiol.13. doi: 10.3389/fcimb.2023.1251135

  • CrossRef
  • Google Scholar

• 138

  VerbekeP.Welter-StahlL.YingS.HansenJ.HäckerG.DarvilleT.et al. (2006). Recruitment of BAD by the chlamydia trachomatis vacuole correlates with host-cell survival. PloS Pathog.2 (5), e45–e45. doi: 10.1371/journal.ppat.0020045

  • CrossRef
  • Google Scholar

• 139

  WanW.LiD.LiD.JiaoJ. (2023). Advances in genetic manipulation of Chlamydia trachomatis. Front. Immunol.14. doi: 10.3389/fimmu.2023.1209879

  • CrossRef
  • Google Scholar

• 140

  WangY.BergE. A.FengX.ShenL.SmithT.CostelloC. E.et al. (2006). Identification of surface-exposed components of MOMP of Chlamydia trachomatis serovar F. Protein Sci.15 (1), 122–134. doi: 10.1110/ps.051616206

  • CrossRef
  • Google Scholar

• 141

  WangX.HybiskeK.StephensR. S. (2017). Orchestration of the mammalian host cell glucose transporter proteins-1 and 3 by Chlamydia contributes to intracellular growth and infectivity. Pathog. Dis.75 (8), ftx108. doi: 10.1093/femspd/ftx108

  • CrossRef
  • Google Scholar

• 142

  WeberM. M.NorieaN. F.BaulerL. D.LamJ. L.SagerJ.WesolowskiJ.et al. (2016). A functional core of incA is required for chlamydia trachomatis inclusion fusion. J. Bacteriol.198 (8), 1347–1355. doi: 10.1128/JB.00933-1510.1128/JB.00933-15

  • CrossRef
  • Google Scholar

• 143

  WehrlW.BrinkmannV.JungblutP. R.MeyerT. F.SzczepekA. J. (2004). From the inside out – processing of the Chlamydial autotransporter PmpD and its role in bacterial adhesion and activation of human host cells. Mol. Microbiol.51 (2), 319–334. doi: 10.1046/j.1365-2958.2003.03838.x

  • CrossRef
  • Google Scholar

• 144

  WesolowskiJ.WeberM. M.NawrotekA.DooleyC. A.CalderonM.St CroixC. M.et al. (2017). Chlamydia hijacks ARF GTPases to coordinate microtubule posttranslational modifications and golgi complex positioning. mBio8 (3), e02280–16. doi: 10.1128/mBio.02280-16

  • CrossRef
  • Google Scholar

• 145

  Whittum-HudsonJ. A.HudsonA. P. (2005). Human chlamydial infections : persistence, prevalence, and outlook for the future. Natures Sci. sociétés13 (4), 371–382. doi: 10.1051/nss:2005057

  • CrossRef
  • Google Scholar

• 146

  WilsonA. C.TanM. (2002). Functional analysis of the heat shock regulator HrcA of Chlamydia trachomatis. J. Bacteriol.184 (23), 6566–6571. doi: 10.1128/JB.184.23.6566-6571.2002

  • CrossRef
  • Google Scholar

• 147

  WitkinS. S.MinisE.AthanasiouA.LeizerJ.LinharesI. M. (2017). Chlamydia trachomatis: the persistent pathogen. Clin. Vaccine Immunol.24 (10), e00203–e00217. doi: 10.1128/CVI.00203-17

  • CrossRef
  • Google Scholar

• 148

  WurihanW.ZouY.WeberA. M.WeldonK.HuangY.BaoX.et al. (2021). Identification of a grgA-euo-hrcA transcriptional regulatory network in chlamydia. mSystems6 (4), e0073821–e0073821. doi: 10.1128/mSystems.00738-21

  • CrossRef
  • Google Scholar

• 149

  YangC.KariL.SturdevantG. L.SongL.PattonM. J.CouchC. E.et al. (2017). Chlamydia trachomatis ChxR is a transcriptional regulator of virulence factors that function in in vivo host–pathogen interactions. Pathog. Dis.75 (3), ftx035. doi: 10.1093/femspd/ftx035

  • CrossRef
  • Google Scholar

• 150

  Yi-ShanC.RobertJ. B.HectorA. S.VictoriaK. C.KristianL. R.GregoryV. P.et al. (2014). The chlamydia trachomatis type III secretion chaperone slc1 engages multiple early effectors, including tepP, a tyrosine-phosphorylated protein required for the recruitment of crkI-II to nascent inclusions and innate immune signaling. PloS Pathog.10 (2), e1003954. doi: 10.1371/journal.ppat.1003954

  • CrossRef
  • Google Scholar

• 151

  ZhangQ.RosarioC. J.SheehanL. M.RizviS. M.BrothwellJ. A.HeC.et al. (2020). The repressor function of the chlamydia late regulator EUO is enhanced by the plasmid-encoded protein pgp4. J. Bacteriol.202 (8), e00793–19. doi: 10.1128/JB.00793-19

  • CrossRef
  • Google Scholar

• 152

  ZhongG. (2016). Chlamydial plasmid-dependent pathogenicity. Trends Microbiol.25 (2), 141–152. doi: 10.1016/j.tim.2016.09.006

  • CrossRef
  • Google Scholar